Adaptin Bio (OTCQB: APTN) Starts Trading on OTCQB Market

May 14, 2026

Expert Analysis Adaptin Bio (OTCQB: APTN) entering the OTCQB Venture Market marks a strategic milestone in expanding its investor base and market presence. This transition highlights the company’s commitment to increasing liquidity and offering enhanced visibility to U.S. investors interested in precision cancer therapeutics. For a biotech firm focused on challenging areas like targeted brain delivery, market accessibility is crucial for sustained growth and development. With the new trading platform,…

Read More >>